|Written by DPR Biocides - Anses|
The transitional regime is defined by Article 89 of Regulation ( EU) No 528/2012: it is the period of time during which the making available on the market and use of biocidal products are governed by the national provisions in force in each Member State, pending approval of all the active substances they contain at European level. When all of a product's active substances have been approved, the transitional regime no longer applies and this product must be authorised in accordance with the BPR. The status of the biocidal active substances, and in particular the approval date of the approved active substances, can be consulted on the website of the European Chemicals Agency (ECHA) .
In France, the placing on the market and use of certain biocidal products previously required national marketing authorisation to be obtained in the transitional period ("transitional" MA). Act No. 2015-1567 of 2 December 2015 has removed this obligation, for products that were subject to this requirement.
The effect of this is not to absolve biocidal product manufacturers and marketing managers from their responsibility with regard to risks to the environment or to human or animal health, related to the placing of their products on the market. Nevertheless, specific provisions remain in force for certain product types including:
In addition, biocidal products must also be brought into compliance with Article 95 of the BPR, with effect from 1 September 2015. Furthermore, products in the transitional regime remain subject to national requirements. They must:
Once the active substances in the product are approved on the EU list of active substances of Regulation (EU) No 528/2012, the products will be subject to the authorisation of ANSES. Companies must submit dossiers in accordance with Decree 2014-1175 of 13 October 2014 .
|Last Updated on Monday, 11 July 2016 14:14|